In cases of CRC where MMR-IHC shows loss of MLH1 and PMS2 protein expression, testing for the BRAF V600E variant or MLH1 promoter methylation can help to exclude sporadic CRC. This evidence concerns the gene MRC1 and colorectal carcinoma.